Corporate Family

Johnson & Johnson

1 Subsidiary

Janssen Biotech, Inc.

People4 people

Industry

Pharmaceutical Preparation Manufacturing

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--

Social Media

Products

Shipping

Rybrevant Faspro ™Therapy

an EGFR - and MET-targeting dual inhibitor

Rybrevant ®Antibody

a first-in-class, fully human bispecific antibody targeting EGFR and MET, designed to inhibit tumor growth while engaging the immune system

Erleada ®

an androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC)